Direct estimate of the haemophilia B (factor IX deficiency) mutation rate and of the ratio of the sex-specific mutation rates in Sweden
- PMID: 1601423
- DOI: 10.1007/BF00220550
Direct estimate of the haemophilia B (factor IX deficiency) mutation rate and of the ratio of the sex-specific mutation rates in Sweden
Abstract
Mutation rates for X-linked recessive diseases have so far been estimated indirectly by postulating an equilibrium between the loss of defective genes caused by the low reproductive fitness of affected males and the gain resulting from new mutations. Here, for the first time, we directly estimate both the overall and sex-specific mutation rates for haemophilia B by detecting the gene defect of the families registered at the Malmö Haemophilia Centre. These represent a complete sample of the Swedish haemophilia B population (45 out of 77 pedigrees) and contain 23 families with a single affected male. Fifteen of these males had mothers available for study, and of these mothers, 13 had parents available for study. We show that 3 of the above patients and 10 of their mothers carry new mutations, and by extrapolation calculate that 8 males and 98 females should carry new haemophilia B mutations in the Swedish population (8.52 x 10(6) individuals). This leads to the following estimate of the mutation rates: overall mu = 4.1 x 10(-6); male specific nu = 2.1 x 10(-5); and female specific mu = 1.9 x 10(-6). The ratio of such male to female specific mutation rates is thus nu/mu = 11.
Similar articles
-
Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity.Br J Haematol. 1991 Jul;78(3):390-7. doi: 10.1111/j.1365-2141.1991.tb04453.x. Br J Haematol. 1991. PMID: 1873221
-
Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations.Haemophilia. 2016 May;22(3):440-5. doi: 10.1111/hae.12854. Epub 2015 Nov 27. Haemophilia. 2016. PMID: 26612714
-
Origin of mutation in sporadic cases of haemophilia-B.Eur J Haematol. 1992 Mar;48(3):142-5. doi: 10.1111/j.1600-0609.1992.tb00585.x. Eur J Haematol. 1992. PMID: 1348478
-
[Haemophilia].Ned Tijdschr Geneeskd. 2014;158:A7357. Ned Tijdschr Geneeskd. 2014. PMID: 25351381 Review. Dutch.
-
Haemophilia B: from molecular diagnosis to gene therapy.Clin Chem Lab Med. 2003 Apr;41(4):445-51. doi: 10.1515/CCLM.2003.067. Clin Chem Lab Med. 2003. PMID: 12747585 Review.
Cited by
-
Haemophilia: strategies for carrier detection and prenatal diagnosis.Bull World Health Organ. 1993;71(3-4):429-58. Bull World Health Organ. 1993. PMID: 8324863 Free PMC article. Review.
-
Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B.Am J Hum Genet. 1999 Dec;65(6):1572-9. doi: 10.1086/302651. Am J Hum Genet. 1999. PMID: 10577910 Free PMC article.
-
A new strategy for the genetic counselling of diseases of marked mutational heterogeneity: haemophilia B as a model.J Med Genet. 1992 Sep;29(9):602-7. doi: 10.1136/jmg.29.9.602. J Med Genet. 1992. PMID: 1404290 Free PMC article. No abstract available.
-
Recurrent mutations in the factor IX gene: founder effect or repeat de novo events. Investigation of the German haemophilia B population and review of de novo mutations.Hum Genet. 1993 Aug;92(1):40-8. doi: 10.1007/BF00216143. Hum Genet. 1993. PMID: 8365725
-
Hemophilia B: molecular pathogenesis and mutation analysis.J Thromb Haemost. 2015 Jul;13(7):1184-95. doi: 10.1111/jth.12958. Epub 2015 May 18. J Thromb Haemost. 2015. PMID: 25851415 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials